
Sign up to save your podcasts
Or


Dr. Bradley Ong discusses evidence for candesartan in migraine prevention.
Show citation:
Øie LR, Wergeland T, Salvesen Ø, et al. Candesartan versus placebo for migraine prevention in patients with episodic migraine: a randomised, triple-blind, placebo-controlled, phase 2 trial. Lancet Neurol. 2025;24(10):817-827. doi:10.1016/S1474-4422(25)00269-8
By American Academy of Neurology4.8
132132 ratings
Dr. Bradley Ong discusses evidence for candesartan in migraine prevention.
Show citation:
Øie LR, Wergeland T, Salvesen Ø, et al. Candesartan versus placebo for migraine prevention in patients with episodic migraine: a randomised, triple-blind, placebo-controlled, phase 2 trial. Lancet Neurol. 2025;24(10):817-827. doi:10.1016/S1474-4422(25)00269-8

328 Listeners

501 Listeners

303 Listeners

54 Listeners

297 Listeners

3,384 Listeners

13 Listeners

1,153 Listeners

27 Listeners

197 Listeners

90 Listeners

518 Listeners

362 Listeners

187 Listeners

82 Listeners